AstraZeneca joins Serum Institute to supply 2 billion doses of coronavirus vaccine <br /> <br />AstraZeneca has agreed terms with Serum Institute of India to supply one billion doses for low and middle-income countries <br /> <br />Britain's AstraZeneca has tied up with Serum Institute of India and two Bill Gates-backed global health organisations as it looks to deliver two billion doses of its potential coronavirus vaccine this year and next, double the previous numbers, <br /> <br />The company, which has already agreed to supply 400 million doses to the United States and British governments, said on June 4 it had agreed terms with Serum Institute of India, the world's largest manufacturer of vaccines by volume, to supply one billion doses for low and middle-income countries. <br /> <br />AstraZeneca's partnership with Oxford University has garnered international attention as one of the leading coronavirus vaccine candidates, sealing more than $1 billion in US government funding last month as it ramps up testing of the vac
